Testosterone-replacement therapy does not increase cardiac events in men with hypogonadism

Nature Reviews Cardiology, Published online: 30 June 2023; doi:10.1038/s41569-023-00909-8Testosterone-replacement therapy in men with hypogonadism and a high risk of cardiovascular disease does not increase the risk of adverse cardiac events, according to data from the TRAVERSE trial.

Source: Nature Reviews Cardiology - June 30, 2023 Category: Cardiology Authors: Gregory B. Lim Source Type: research